PGC1α-Mediated Metabolic Reprogramming Drives the Stemness of Pancreatic Precursor Lesions.
Rama Krishna NimmakayalaSatyanarayana RachaganiRamakanth Chirravuri VenkataSaravanakumar MarimuthuPalanisamy NallasamyRaghupathy VengojiSubodh M LeleSatyanarayana RachaganiKavita MallyaMokenge P MalafaMoorthy P PonnusamySurinder K BatraPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
ADM/PanINs and IPMNs show specific stemness signatures with unique metabolisms. Inhibition of PGC1α using SR18292 diminishes the specific stemness by targeting FAO-independent and FAO-dependent OXPhos of ADM/PanINs and IPMNs, respectively.